Reviral Limited – Successful Series A
- September 3, 2015
- No comments
Theobald Associates is pleased to announce the successful closing of a Series A Fundraising for its client, the UK-based antiviral drug discovery Company Reviral Limited. The transaction raised USD$21 million in a funding round lead by a group of prominent venture capital investors including Edmond de Rothschild Investment Partners, Orbimed, and Brace Pharma Capital. Further details can be found HERE.